Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0001439222-24-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-11 | 2024-03-07 | AGIO | Foster-Cheek Kaye I | Dir | S - Sale | $31.62 | -1,285 | 5,524 | -19% | -$40.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-03-07 | S | D | 1,285 | $31.62 | 5,524 | D | — | — |